⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LENZ News
LENZ Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
LENZ
LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
globenewswire.com
LENZ
LENZ Therapeutics to Report Second Quarter 2026 Financial Results and Recent Corporate Highlights on August 11, 2026
globenewswire.com
LENZ
LENZ Therapeutics Announces Launch of New Telehealth Prescribing Option to Accelerate Patient Access to VIZZ® for the Treatment of Presbyopia
globenewswire.com
LENZ
Form 8-K
sec.gov
LENZ
LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Australia and New Zealand
globenewswire.com
LENZ
Form 8-K
sec.gov
LENZ
LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China
globenewswire.com
LENZ
LENZ Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
LENZ
Form 8-K
sec.gov
LENZ